Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease

9 Feb 2025 09:18 09:36
VladoPerkovic Oral Abstract Presenter AustraliaUniversity of New South Wales, Sydney, Australia